Use access key #2 to skip to page content.
$61.21 -2.35 (-3.70%)
12/4/2008 4:00 PM

Genzyme Corp (GENZ)

CAPS Rating:
*****

A biotechnology company dedicated to making an impact on the lives of people with serious diseases. Its product and service portfolio is focused on rare disorders, renal diseases, orthopaedics, organ transplant, and diagnostic and predictive testing.

View All Commentary (GENZ)

Recs

0

Avatar BetterMoney77 (< 20) Submitted: 12/11/07 11:12 AM : Outperform Start Price: $73.53 GENZ Score: 27.05

Big profitability looking forward (accelerating growth)

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners

Sponsored Links